Emily F Kauvar1, Maximilian Muenke. 1. Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland 20892-3717, USA.
Abstract
PURPOSE OF REVIEW: This review presents recent advances in our understanding and clinical management of holoprosencephaly (HPE). HPE is the most common developmental disorder of the human forebrain and involves incomplete or failed separation of the cerebral hemispheres. The epidemiology, clinical features, causes, diagnostic approach, management, and outcomes of HPE are discussed. RECENT FINDINGS: Chromosomal abnormalities account for the most commonly identified cause of HPE. However, there are often unidentifiable causes in patients with nonsyndromic, nonchromosomal forms of HPE. The prevalence of HPE may be underestimated given that patients with mild forms often are not diagnosed until they present with severely affected children. Pregestational maternal diabetes mellitus is the most recognized risk factor for HPE, as supported by recent large-scale epidemiological studies. Genetic studies using microarray-based comparative genomic hybridization technology have resulted in better characterization of important HPE loci. SUMMARY: HPE encompasses a wide spectrum of forebrain and midline defects, with an accompanying wide spectrum of clinical manifestations. A coordinated, multidisciplinary care team is required for clinical management of this complex disorder. Further research will enable us to better understand the pathogenesis and causes of HPE, and thus to improve the genetic counseling of patients and their families.
PURPOSE OF REVIEW: This review presents recent advances in our understanding and clinical management of holoprosencephaly (HPE). HPE is the most common developmental disorder of the human forebrain and involves incomplete or failed separation of the cerebral hemispheres. The epidemiology, clinical features, causes, diagnostic approach, management, and outcomes of HPE are discussed. RECENT FINDINGS:Chromosomal abnormalities account for the most commonly identified cause of HPE. However, there are often unidentifiable causes in patients with nonsyndromic, nonchromosomal forms of HPE. The prevalence of HPE may be underestimated given that patients with mild forms often are not diagnosed until they present with severely affected children. Pregestational maternal diabetes mellitus is the most recognized risk factor for HPE, as supported by recent large-scale epidemiological studies. Genetic studies using microarray-based comparative genomic hybridization technology have resulted in better characterization of important HPE loci. SUMMARY: HPE encompasses a wide spectrum of forebrain and midline defects, with an accompanying wide spectrum of clinical manifestations. A coordinated, multidisciplinary care team is required for clinical management of this complex disorder. Further research will enable us to better understand the pathogenesis and causes of HPE, and thus to improve the genetic counseling of patients and their families.
Authors: F Lacbawan; B D Solomon; E Roessler; K El-Jaick; S Domené; J I Vélez; N Zhou; D Hadley; J Z Balog; R Long; A Fryer; W Smith; S Omar; S D McLean; K Clarkson; A Lichty; N J Clegg; M R Delgado; E Levey; E Stashinko; L Potocki; M I Vanallen; J Clayton-Smith; D Donnai; D W Bianchi; P B Juliusson; P R Njølstad; H G Brunner; J C Carey; U Hehr; J Müsebeck; P F Wieacker; A Postra; R C M Hennekam; M-J H van den Boogaard; A van Haeringen; A Paulussen; J Herbergs; C T R M Schrander-Stumpel; A R Janecke; D Chitayat; J Hahn; D M McDonald-McGinn; E H Zackai; W B Dobyns; M Muenke Journal: J Med Genet Date: 2009-04-02 Impact factor: 6.318
Authors: Sandra Mercier; Christèle Dubourg; Marion Belleguic; Laurent Pasquier; Philippe Loget; Josette Lucas; Claude Bendavid; Sylvie Odent Journal: Am J Med Genet C Semin Med Genet Date: 2010-02-15 Impact factor: 3.908
Authors: Eric B Levey; Elaine Stashinko; Nancy J Clegg; Mauricio R Delgado Journal: Am J Med Genet C Semin Med Genet Date: 2010-02-15 Impact factor: 3.908
Authors: Elaine E Stashinko; Leslie A Harley; Roxanne A Steele; Nancy J Clegg Journal: Am J Med Genet C Semin Med Genet Date: 2010-02-15 Impact factor: 3.908
Authors: Amelia A Keaton; Benjamin D Solomon; Anthonie J van Essen; Kathleen M Pfleghaar; Michael A Slama; Judith A Martin; Maximilian Muenke Journal: Am J Med Genet C Semin Med Genet Date: 2010-02-15 Impact factor: 3.908
Authors: Benjamin D Solomon; Daniel E Pineda-Alvarez; Sandra Mercier; Manu S Raam; Sylvie Odent; Maximilian Muenke Journal: Am J Med Genet C Semin Med Genet Date: 2010-02-15 Impact factor: 3.908
Authors: Lucilene A Ribeiro; Erich Roessler; Ping Hu; Daniel E Pineda-Alvarez; Nan Zhou; Marypat Jones; Settara Chandrasekharappa; Antonio Richieri-Costa; Maximilian Muenke Journal: Birth Defects Res A Clin Mol Teratol Date: 2012-07-27
Authors: Qing Fang; Akima S George; Michelle L Brinkmeier; Amanda H Mortensen; Peter Gergics; Leonard Y M Cheung; Alexandre Z Daly; Adnan Ajmal; María Ines Pérez Millán; A Bilge Ozel; Jacob O Kitzman; Ryan E Mills; Jun Z Li; Sally A Camper Journal: Endocr Rev Date: 2016-11-09 Impact factor: 19.871
Authors: Li Zhao; Solsire E Zevallos; Karine Rizzoti; Yongsu Jeong; Robin Lovell-Badge; Douglas J Epstein Journal: Dev Cell Date: 2012-03-13 Impact factor: 12.270